BEYHAN ÖZDAŞ, Ş. Et Al. 2015. Is mesenchymal stem cell therapy suitable for reducing insulin resistance ın fructose induced metabolic syndrome rat model. 1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders , (Turkey).

BEYHAN ÖZDAŞ, Ş., AKIN, D., DEMİRCAN, G., YAPIŞLAR, H., KETENCİ, S., KOLDEMİR GÜNDÜZ, M., ... ÇEVİK, M.(2015). Is mesenchymal stem cell therapy suitable for reducing insulin resistance ın fructose induced metabolic syndrome rat model . 1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders, Turkey

BEYHAN ÖZDAŞ, ŞULE Et Al. "Is mesenchymal stem cell therapy suitable for reducing insulin resistance ın fructose induced metabolic syndrome rat model," 1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders, Turkey, 2015

BEYHAN ÖZDAŞ, ŞULE B. Et Al. "Is mesenchymal stem cell therapy suitable for reducing insulin resistance ın fructose induced metabolic syndrome rat model." 1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders , Turkey, 2015

BEYHAN ÖZDAŞ, Ş. Et Al. (2015) . "Is mesenchymal stem cell therapy suitable for reducing insulin resistance ın fructose induced metabolic syndrome rat model." 1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders , Turkey.

@conferencepaper{conferencepaper, author={ŞULE BEYHAN ÖZDAŞ Et Al. }, title={Is mesenchymal stem cell therapy suitable for reducing insulin resistance ın fructose induced metabolic syndrome rat model}, congress name={1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders}, city={}, country={Turkey}, year={2015}}